Overview
According to market.us, The global 2,5-Dibromopyrazine market is projected to reach approximately USD 345.9 million by 2034, rising from USD 202.1 million in 2024, reflecting a compound annual growth rate (CAGR) of 5.5% between 2025 and 2034. 2,5-Dibromopyrazine, identified by CAS number 23229-26-7, is an organic compound with the molecular formula C₄H₂Br₂N₂ and a molecular weight of 237.88. It typically appears as a white to light yellow solid powder at room temperature and has a melting point range of 45 to 49 degrees Celsius. The compound exhibits a density of 2.2 and is soluble in polar solvents, though it remains insoluble in water.
Belonging to the class of heterocyclic aromatic compounds, 2,5-Dibromopyrazine plays a vital role in organic synthesis, primarily serving as an intermediate in the manufacturing of various chemical products. Its functional properties and reactivity make it a valuable component in industrial chemical processes.
The 2,5-Dibromopyrazine market is witnessing steady growth, driven by its increasing use across multiple industries. In the pharmaceutical sector, it serves as a crucial intermediate in the synthesis of biologically active compounds, playing a significant role in drug discovery and development processes. In agrochemicals, the compound is employed in the formulation of pesticides and herbicides designed to offer enhanced environmental compatibility. Additionally, the dye and pigment industry relies on 2,5-Dibromopyrazine for producing high-performance colorants. Its applications extend into material science as well, where it contributes to the development of advanced materials, including luminescent and conductive substances, further reinforcing its industrial significance.
Click here to get a Sample report copy@ https://market.us/report/2-5-dibromopyrazine-market/free-sample/
Key Takeaways
- The global 2, 5-Dibromopyrazine market was valued at USD 202.1 million in 2024.
- The global 2, 5-Dibromopyrazine market is projected to grow at a CAGR of 5.5% and is estimated to reach USD 345.9 million by 2034.
- Among purities, up to 98% accounted for the largest market share at 74.6%.
- Among applications, pharmaceuticals accounted for the majority of the market share at 58.8%.
- North America is estimated as the largest market for 2, 5-Dibromopyrazine with a share of 37.1% of the market share.
- Asia-Pacific is anticipated to register the highest CAGR of 6.2%.
- Europe with a revenue share of 30.7% in 2024 and expected to register a CAGR of 5.2%.
Factors Affecting the Growth of the 2,5-Dibromopyrazine Market
- Rising Demand from the Pharmaceutical Industry: The pharmaceutical sector represents one of the primary drivers of growth for the 2,5-Dibromopyrazine market. This compound is widely used as a key intermediate in the synthesis of biologically active molecules, particularly in the development of drugs targeting complex diseases such as cancer and neurological disorders. As pharmaceutical R&D activities expand globally, the demand for efficient and reliable intermediates like 2,5-Dibromopyrazine continues to rise.
- Growth in Agrochemical Applications: 2,5-Dibromopyrazine Market is increasingly utilized in the production of herbicides and pesticides. With global concerns over food security and the need for higher agricultural productivity, the agrochemical sector is witnessing growth. This trend directly boosts the market for intermediates involved in crop protection formulations, especially compounds that offer environmental benefits and targeted efficacy.
- Expansion of Specialty Chemicals and Advanced Materials: Beyond pharmaceuticals and agrochemicals, this compound is gaining traction in material sciences, where it is employed in the development of conductive and luminescent materials. The growing focus on smart materials and specialty chemical applications—especially in electronics and high-performance coatings—is contributing to greater demand for structurally reliable intermediates like 2,5-Dibromopyrazine.
- Favorable Regulatory Support in Key Markets: The regulatory inclusion of 2,5-Dibromopyrazine in frameworks such as the U.S. TSCA and EU REACH ensures its availability and compliance across major economies. These clear guidelines support manufacturer confidence and facilitate smoother trade and usage, thereby encouraging market expansion.
Segmentation Analysis
Purity Analysis: In 2024, 2,5-Dibromopyrazine with up to 98% purity accounted for a dominant 74.6% share of the global market. This segment’s strong performance is attributed to its widespread application across industries where ultra-high purity is not essential. It is commonly utilized as a cost-effective intermediate in the synthesis of various compounds within the pharmaceutical, agrochemical, and specialty chemical sectors. The segment benefits from a favorable balance between functionality and production economics, making it suitable for large-scale industrial processes that do not demand purities above 98%.
Application Analysis: In terms of application, the pharmaceutical industry led the 2,5-Dibromopyrazine market in 2024, capturing a substantial 58.8% share. The compound is extensively employed as a key intermediate in the synthesis of pharmacologically active agents. Its chemical properties make it highly suitable for developing therapeutic compounds aimed at treating complex diseases, including cancer and neurological disorders. The critical role of such intermediates in modern drug development underpins the pharmaceutical sector’s dominant market position.
Market Segments
By Purity
- Up to 98%
- Above 98%
By Application
- Pharmaceutical
- Dyes & Pigments
- Agrochemicals
- Material Science
- Chemical Synthesis
To Purchase this Premium Report@ https://market.us/purchase-report/?report_id=141083
Regulatory Framework
The regulatory framework governing 2,5-Dibromopyrazine varies across regions, with strict compliance requirements in place to ensure safe handling and use. In the United States, the compound is classified as a hazardous chemical under the 2012 OSHA Hazard Communication Standard (29 CFR 1910.1200). This classification necessitates proper labeling and the provision of safety data sheets (SDS) to communicate potential hazards effectively. Additionally, 2,5-Dibromopyrazine is listed under the Toxic Substances Control Act (TSCA), which requires manufacturers to inform the U.S. Environmental Protection Agency (EPA) about the production and application of specific substances.
The compound is currently recognized as an active chemical in the TSCA inventory. In the European Union, the compound is regulated under the REACH (Registration, Evaluation, Authorization and Restriction of Chemicals) framework. According to REACH, manufacturers and importers must register 2,5-Dibromopyrazine with the European Chemicals Agency (ECHA) if the quantity produced or imported exceeds one ton per year. These regulatory measures highlight the importance of monitoring the production, use, and potential risks associated with the compound across key markets.
Market Key Players
- Vesino Industrial Co., Ltd.
- Win-Win Chemical CO., Limited
- SAGECHEM
- Shanghai Ruifu Chemical Co., Ltd.
- ENAO Chemical Co., Ltd
- Hunan Jiahang
- Pharmaceutical Technology Co., Ltd.
- Amitychem Corporation
- Puyer Group
- Zhengzhou Alfa Chemical Co., Ltd.
- Hangzhou Keying Chem Co., Ltd.
- abcr GmbH
- Chemneo Chemicals
- Other Key Players
Regional Analysis
In 2024, North America emerged as the leading region in the global 2,5-Dibromopyrazine market, holding a dominant share of 37.1%. This leadership position is primarily attributed to the region’s well-established pharmaceutical, agrochemical, and specialty chemical industries. 2,5-Dibromopyrazine serves as a vital intermediate in the synthesis of active compounds used in a wide range of pharmaceutical applications, particularly those addressing neurological and infectious diseases, as well as in agrochemical formulations for crop protection. The United States, in particular, is home to several major pharmaceutical and agrochemical companies, which contributes to the steady and increasing demand for specialized intermediates such as 2,5-Dibromopyrazine across the region.
Conclusion
In conclusion, the global 2,5 Dibromopyrazine market is positioned for steady and sustained growth through 2034, underpinned by a compound annual growth rate of approximately 5–6%. The market’s expansion is supported by strong demand across key end-use sectors—most notably pharmaceuticals, agrochemicals, dyes and pigments, and advanced materials—where 2,5 Dibromopyrazine serves as a versatile and cost-effective chemical intermediate. These industries benefit from its functional properties and favorable purity-cost balance.
Get in Touch with Us:
Market.us (Powered By Prudour Pvt. Ltd.)
Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States
Send Email: [email protected]
View More reports
Trans-2, 6-Dimethylmorpholine Market
